Literature DB >> 35912058

Correlation between placental histopathology and perinatal outcome in COVID-19.

Devendra Arora1, K S Rajmohan2, Sanjay Singh1, Vinod Nair1, Sanghita Barui2, Madhusudan Dey1, Abhijeet Kumar1.   

Abstract

Objectives: An alarming rate of adverse perinatal outcomes as well as maternal deaths has been reported worldwide during this pandemic. It would be prudent to start thinking on the lines of acute or chronic intrauterine fetal hypoxia due to placental microvascular pathology or villitis caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection. Autopsy studies of deceased patients with severe COVID-19 have revealed the presence of diffuse pulmonary alveolar damage, thrombosis, and microvascular injuries. It is expected that similar pathological features such as microvascular injuries could be found in the placenta of infected pregnant women. Materials and
Methods: Placentas of singleton pregnancies from 42 SARS-CoV-2 positive mothers delivered at term were submitted for histopathological examination. Those with multifetal gestation, hypertensive disorder, fetal growth restriction, structural or chromosomal anomalies in the fetus, thrombophilia, prolonged prelabor rupture of membranes, and placenta accreta spectrum were excluded from the study. Histopathological examination was done by two pathologists independently and only those results concurred by both were reported. Histopathological features and corresponding neonatal outcome were analyzed.
Results: Reports of 42 placentas from patients with SARS-CoV-2, delivered at term (37-40 weeks) were analyzed in our study. Features of maternal vascular malperfusions (MVM) were present in 45% (n = 19) cases. Features of fetal vascular malperfusions (FVM) were present in 23.8% (n = 10) cases. There were 47.6% (n = 20) cases showing at least one feature of acute inflammatory pathology (AIP) and 42.8% (n = 18) showing features of chronic inflammatory pathology (CIP). Neonatal respiratory distress syndrome was found in 19% (n = 8) of the neonates. Correspondingly, nearly all placentas (n = 7) of these neonates showed features of MVM, FVM, AIP and CIP. There was no maternal or neonatal mortality in our study group.
Conclusion: The main findings of our study include maternal as well as fetal vascular malperfusions and placental inflammatory pathology. These findings provide an outline for better understanding of etiological factors and pathogenesis of adverse perinatal outcomes in SARS-CoV-2 infection. Copyright:
© 2022 Tzu Chi Medical Journal.

Entities:  

Keywords:  COVID-19; Histopathology; Perinatal outcome; Placenta; Pregnancy

Year:  2022        PMID: 35912058      PMCID: PMC9333102          DOI: 10.4103/tcmj.tcmj_233_21

Source DB:  PubMed          Journal:  Tzu Chi Med J        ISSN: 1016-3190


  37 in total

1.  Reference values for singleton and twin placental weights.

Authors:  H Pinar; C J Sung; C E Oyer; D B Singer
Journal:  Pediatr Pathol Lab Med       Date:  1996 Nov-Dec

Review 2.  Fetal vascular malperfusion, an update.

Authors:  Raymond W Redline; Sanjita Ravishankar
Journal:  APMIS       Date:  2018-07       Impact factor: 3.205

3.  Umbilical cord diameter percentile curves and their correlation to birth weight and placental pathology.

Authors:  L K Proctor; B Fitzgerald; W L Whittle; N Mokhtari; E Lee; G Machin; J C P Kingdom; S J Keating
Journal:  Placenta       Date:  2012-11-19       Impact factor: 3.481

4.  Detection of cytomegalovirus, herpes virus simplex, and parvovirus b19 in spontaneous abortion placentas.

Authors:  Gabriela Mafra de Oliveira; Marcelo Antônio Pascoal-Xavier; Daniel R Moreira; Vitor Souza Guimarães; Regina Amélia Lopes Pessoa de Aguiar; Débora Marques de Miranda; Roberta Maia de Castro Romanelli
Journal:  J Matern Fetal Neonatal Med       Date:  2017-11-07

Review 5.  The placenta in pre-eclampsia and intrauterine growth restriction.

Authors:  D J Roberts; M D Post
Journal:  J Clin Pathol       Date:  2008-07-19       Impact factor: 3.411

6.  Fetal vascular malperfusion (FVM): diagnostic implications and clinical associations.

Authors:  Gayatri Ravikumar; Dwayne Mascarenhas; P N Suman Rao; Julian Crasta
Journal:  J Matern Fetal Neonatal Med       Date:  2020-12-01

7.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.

Authors:  Chaolin Huang; Yeming Wang; Xingwang Li; Lili Ren; Jianping Zhao; Yi Hu; Li Zhang; Guohui Fan; Jiuyang Xu; Xiaoying Gu; Zhenshun Cheng; Ting Yu; Jiaan Xia; Yuan Wei; Wenjuan Wu; Xuelei Xie; Wen Yin; Hui Li; Min Liu; Yan Xiao; Hong Gao; Li Guo; Jungang Xie; Guangfa Wang; Rongmeng Jiang; Zhancheng Gao; Qi Jin; Jianwei Wang; Bin Cao
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

8.  Lung Histopathology in Coronavirus Disease 2019 as Compared With Severe Acute Respiratory Sydrome and H1N1 Influenza: A Systematic Review.

Authors:  Lida P Hariri; Crystal M North; Angela R Shih; Rebecca A Israel; Jason H Maley; Julian A Villalba; Vladimir Vinarsky; Jonah Rubin; Daniel A Okin; Alyssa Sclafani; Jehan W Alladina; Jason W Griffith; Michael A Gillette; Yuval Raz; Christopher J Richards; Alexandra K Wong; Amy Ly; Yin P Hung; Raghu R Chivukula; Camille R Petri; Tiara F Calhoun; Laura N Brenner; Kathryn A Hibbert; Benjamin D Medoff; C Corey Hardin; James R Stone; Mari Mino-Kenudson
Journal:  Chest       Date:  2020-10-07       Impact factor: 9.410

9.  A Novel Coronavirus from Patients with Pneumonia in China, 2019.

Authors:  Na Zhu; Dingyu Zhang; Wenling Wang; Xingwang Li; Bo Yang; Jingdong Song; Xiang Zhao; Baoying Huang; Weifeng Shi; Roujian Lu; Peihua Niu; Faxian Zhan; Xuejun Ma; Dayan Wang; Wenbo Xu; Guizhen Wu; George F Gao; Wenjie Tan
Journal:  N Engl J Med       Date:  2020-01-24       Impact factor: 91.245

10.  Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): a global pandemic and treatment strategies.

Authors:  Atul Sharma; Swapnil Tiwari; Manas Kanti Deb; Jean Louis Marty
Journal:  Int J Antimicrob Agents       Date:  2020-06-10       Impact factor: 15.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.